Nilotinib appears safe in Parkinson’s trial; drug thought to allow dopamine replenishment

WASHINGTON – A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of…

Nilotinib appears safe in Parkinson’s trial; drug thought to allow dopamine replenishment

WASHINGTON – A clinical trial investigating the repurposed cancer drug nilotinib in people with Parkinson’s disease finds that it is reasonably safe and well tolerated. Researchers also report finding an increase in dopamine, the chemical lost as a result of…

Blood pressure drug could help problem drinkers: QUT research

A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells, research at the Queensland University of…

Blood pressure drug could help problem drinkers: QUT research

A drug used to treat high blood pressure may alleviate anxiety induced by long-term heavy alcohol use, and also halt the damage such drinking can cause to the brain’s ability to grow new cells, research at the Queensland University of…

Common genetic link between autism and Tourette’s impairs brain communication

Lancaster University researchers have discovered, for the first time, how a genetic alteration that increases the risk of developing Autism and Tourette’s impacts on the brain. Their research also suggests that ketamine, or related drugs, may be a useful treatment…

Neurorestore: A Swiss initiative aimed at restoring lost neurological function

The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again

Neurorestore: A Swiss initiative aimed at restoring lost neurological function

The Defitech Foundation has teamed up with EPFL, CHUV and UNIL to widen access to the groundbreaking neurotechnology developed under the 2018 STIMO study, which allowed paraplegic patients to walk again

New diagnostic techniques and drug may slow and even reverse cognitive decline from aging

BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…

New diagnostic techniques and drug may slow and even reverse cognitive decline from aging

BEER-SHEVA, ISRAEL and BERKELEY, CALIFORNIA…DECEMBER 4, 2019 – A groundbreaking clinical approach has been developed combining new diagnostic techniques to detect a leaking blood-brain barrier (BBB) with a new anti-inflammatory drug that for the first time slows or reverses age-related…

Georgia State chemistry professor honored as National Academy of Inventors Fellow

ATLANTA–Jenny Yang, a Regents’ Professor of chemistry at Georgia State University and the associate director of the Center for Diagnostics and Therapeutics, has been selected as a National Academy of Inventors (NAI) Fellow, the academy board announced on Tuesday. Yang,…

Georgia State chemistry professor honored as National Academy of Inventors Fellow

ATLANTA–Jenny Yang, a Regents’ Professor of chemistry at Georgia State University and the associate director of the Center for Diagnostics and Therapeutics, has been selected as a National Academy of Inventors (NAI) Fellow, the academy board announced on Tuesday. Yang,…

NUS researchers use machine learning tools to reveal how memories are coded in the brain

NUS researchers have made a breakthrough in the field of cognitive computational neuroscience, by discovering a key aspect of how the brain encodes short-term memories. The researchers working in The N.1 Institute for Health at the National University of Singapore…